Epigenome-wide CpG methylation was profiled using either the Illumina HumanMethylation450 BeadChip (450K) (San Diego, CA, USA) in the MESA (monocyte), YSCCS (blood), and VACS (blood) (57.2% of the sample) cohorts or Illumina HumanMethylation EPIC BeadChip (EPIC) (San Diego, CA, USA) in 42.8% of the VACS samples and the WIHS (peripheral blood mononuclear cells) samples. All samples in the three study cohorts (YSCCS, VACS, and WIHS) were processed at the Yale Center for Genomic Analysis (Zhang et al., 2017 (link)). We applied the method described by Houseman et al. (Houseman et al., 2012 (link), Jaffe and Irizarry, 2014 (link)) to estimate the proportions of CD4+ T cells, CD8+ T cells, NK T cells, B cells, monocytes, and granulocytes in each cohort. Quality control of methylation data for each cohort is presented in Supplementary Information.